Asep Medical Holdings Inc

Asep Medical Holdings Inc

ASEP.CN
Asep Medical Holdings IncCA flagCanadian Securities Exchange
0.13
CAD
-0.18
- -
1.45MMarket Cap
Asep Medical Holdings Inc
ASEP.CN
(Canadian Securities Exchange)

Recent

price

0.13

P/E

ratio

- -

div

yld

- -

ROIC.AI

2021
2022
2023
2024
2025
TTM
FRC
- -
- -
- -
- -
0.03
0.03
Revenue per Share
-0.39
-0.81
-1.32
- -
-0.48
-0.61
Basic EPS, GAAP
-0.22
-0.64
-0.44
- -
-0.12
-0.15
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
3.08
2.33
1.46
- -
-0.11
0.93
Book Value per Share
1.01
0.52
-0.06
- -
-0.23
-0.28
Tangible Book Value per Share
6
6
6
- -
10
8
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
-36,524.42
- -
-761.37
-2,017.8
Operating Margin (%)
- -
1
1
- -
1
1
Depreciation Expense
-2
-5
-8
- -
-5
-5
Net Income, GAAP
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
-38,918.3
- -
-1,459.7
-1,900.29
Profit Margin (%)
6
3
-1
- -
-2
-2
Working Capital
- -
- -
- -
- -
- -
- -
LT Debt
31
27
23
- -
4
20
Total Equity
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-29.79
-74.19
- -
- -
-55.44
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Mar'24
Jun'24
Sep'24
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
8
8
8
Market Capitalization
11
9
8

Working Capital

FRC

in mil. unless spec.
Mar'24
Jun'24
Sep'24
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
2
2
Payables & Accruals
1
2
2
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-80.78%
Free Cash Flow
- -
- -
-55.18%
Net Income, GAAP
- -
- -
-40.25%
Sales/Revenue/Turnover
- -
- -
1,493.06%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.1
-0.15
-0.1
- -
- -
2025
- -
-0.04
- -
- -
-0.48
2026
-0.02
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Asep Medical Holdings Inc is a medical device company specializing in the design, development, manufacturing, and sale of minimally invasive surgical equipment and endoscopic products. Its core product offerings include cystoscopes, laparoscopes, hysteroscopes, surgical instrumentation, and other related surgical visualization systems primarily targeting urology, gynecology, and general surgery markets. The company provides its products mainly to hospitals, surgical centers, and healthcare providers across North America, with its headquarters located in Mississauga, Ontario, Canada. Founded in 2003, Asep Medical serves the medical device industry with a particular focus on innovation in minimally invasive surgical technology. In recent developments over the last 1-2 years, Asep Medical Holdings has expanded its product portfolio by introducing advanced endoscopic imaging systems enhancing surgical precision and operational efficiency. Additionally, the company has cultivated strategic partnerships with distributors and healthcare institutions to broaden market penetration in the U.S. and Canadian surgical equipment markets. The company continues its commitment to research and development to maintain technological leadership and address the evolving needs of surgical professionals. There have been no reports of significant rebranding or organizational restructuring during this period. Overall, Asep Medical Holdings operates within the medical device and healthcare equipment industry segment, concentrating on medical endoscopy and surgical solutions. Its products cater to surgeons and healthcare providers specializing in minimally invasive procedures. The company has established a solid presence in North American markets, leveraging its Canadian base and medical expertise to supply critical surgical instrumentation and endoscopic technologies to healthcare facilities. Asep Medical Holdings remains focused on innovation, quality manufacturing, and expanding its service support capabilities to strengthen its competitive positioning in the medical device sector.